Type 2 diabetes

Cover; Contents; Preface to the first edition; Symbols and abbreviations; Contributors; 1. Complications and costs of diabetes; 2. Pathophysiology of type 2 diabetes; 3. Interpretation of recent clinical trials concerning tight glycaemic control and cardiovascular risk; 4. Pharmacotherapy in type 2 diabetes: clinical evidence; 5. Multiple cardiovascular risk intervention; 6. Diet, exercise and other lifestyle factors; 7. Managing glycaemia--current oral agents; 8. Managing glycaemia: recently introduced and future therapies; 9. Management of type 2 diabetes and insulin; 10. Challenges to good diabetes care Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X

Around 250 million people currently suffer from diabetes globally and this number is expected to reach 370 million people within the next 20 years. Fortunately in recent years our understanding of the pathogenesis and management of Type 2 diabetes has increased enormously. Innovative new drugs have been developed and the evidence base for treating diabetes and preventing its complications is now outstanding. This second edition has been fully updated throughout to include all of the latest trial data, including new chapters on pathophysiology, and interpretation of recent clinical trials. This pocketbook is a concise, practical guide to the diagnosis, assessment and management of Type 2 Diabetes aimed at clinicians, GPs and nurse specialists. With contributions from leading diabetes experts, the information in this book is presented in an easy to use format and is supplemented with key figures and tables.